Joshua David Penfield, MBCHB

Joshua Penfield practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Joshua Penfield's NPI, 1356508402, was assigned on May 16, 2008. Joshua Penfield graduated from Warwick Medical School in 2004. Joshua Penfield holds California license C170560.

Joshua Penfield's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Joshua Penfield's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Joshua Penfield is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Joshua Penfield to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joshua Penfield practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Joshua Penfield's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Joshua Penfield is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Joshua Penfield's licenses on file in 5 states: California, Maine, Washington, Minnesota and Ohio.

Dmand AI lists chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, hepatitis c, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Joshua Penfield treats.

CMS data shows 874 Medicare services from Joshua Penfield across 9 procedure codes in 2024, for 165 Medicare patients. Medicare paid $37,979 for them.

CMS counts 165 Medicare patients who saw Joshua Penfield in 2024. The largest group is 65 to 74, with 90 patients. 65% of them have high blood pressure, and 61% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Joshua Penfield's median patient age at 64, with 52% women.

In 2024, Joshua Penfield wrote 288 Medicare Part D claims for 118 patients. 79% of them were for generic drugs. CMS names the drug for 151 of them, across 6 drugs with 11 or more claims each, at $21,218 in total drug cost. In 2023, CMS named 119 claims across 3 drugs.

Joshua Penfield accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 83 procedures of colonoscopy by Joshua Penfield, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Joshua Penfield, published from 2012 to 2022. The most frequent topics are Esophagus. Joshua Penfield has published most often in Am J Gastroenterol. Joshua Penfield's most frequent co-authors are Cynthia Wilson Baffi, MD, Todd H. Baron, MD and Jonathan Joseph Cho, MD, PhD.

CMS Open Payments shows 9 general payments to Joshua Penfield from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Olympus America Inc. paid the most, $154.

Joshua Penfield graduated from Warwick Medical School in 2004.

Joshua Penfield is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.